Nonspecific low back pain: Assessment of available medications

Joint Bone Spine

Volumn 79, Issue 2, 2012, Pages 134-136

  Bannwarth, Bernard ^a   Kostine, Marie ^a   Shipley, Emilie ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

Analgesics; Metaanalysis; Nonspecific low back pain; Randomized controlled trials

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BACLOFEN; CYCLOBENZAPRINE; DANTROLENE; DICLOFENAC; ETORICOXIB; GABAPENTIN; GLUCOCORTICOID; IMIPRAMINE; LOCAL ANESTHETIC AGENT; METHOCARBAMOL; MORPHINE; MUSCLE RELAXANT AGENT; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PARACETAMOL; PAROXETINE; PREGABALIN; THIOCOLCHICOSIDE; TIZANIDINE; TOPIRAMATE; TRAMADOL;

ADD ON THERAPY; ADJUVANT THERAPY; ANALGESIA; CHRONIC PAIN; DRUG EFFICACY; DRUG SAFETY; HUMAN; LOW BACK PAIN; MANIPULATIVE MEDICINE; META ANALYSIS (TOPIC); MONOTHERAPY; MUSCLE SPASM; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT SURVEY; SYSTEMATIC REVIEW (TOPIC); VISUAL ANALOG SCALE;

ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIDEPRESSIVE AGENTS; HUMANS; LOW BACK PAIN; NEUROMUSCULAR AGENTS; TREATMENT OUTCOME;

EID: 84857801910     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2011.06.008     Document Type: Short Survey

References (28)

1. Machado L.A., Kamper S.J., Herbert R.D., et al. Analgesic effects of treatment for non- specific low back pain: a meta-analysis of placebo-controlled randomized trials. Rheumatology 2009, 48:520-527.
2. Wilkens P., Scheel I.B., Grundnes O., et al. Effect of glucosamine on pain-related disability in patients with chronic low back pain and degenerative lumbar osteoarthritis. A randomized controlled trial. JAMA 2010, 304:45-52.
3. Mauro G., Martorana U., Cataldo P., et al. Vitamin B12 in low back pain: a randomised, double-blind, placebo-controlled study. Eur Rev Med Pharmacol Sci 2000, 4:53-58.
4. Morlion B. Pharmacotherapy of low back pain: targeting nociceptive and neuropathic pain components. Curr Med Res Opin 2011, 27:11-33.
5. Van Tulder M.W., Scholten R.J., Koes B.W., et al. Nonsteroidal anti-inflammatory drugs for low back pain. A systematic review within the framework of the Cochrane collaboration back review group. Spine 2000, 25:2501-2513.
6. Van Tulder M., Becker A., Bekkering T., et al. European guidelines for the management of acute nonspecific low back pain in primary care. Eur Spine J 2006, 15:169-191.
7. Handcock M.J., Maher C.G., Latimer J., et al. Assessment of diclofenac or spinal manipulative therapy, or both, in addition to recommended first-line treatment for acute low back pain: a randomised controlled trial. Lancet 2007, 370:1638-1643.
8. Roelofs P.D., Deyo R.A., Koes B.W., et al. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev 2008, CD000396.
9. Cochrane D.J., Jarvis B., Keating G.M. Etoricoxib. Drugs 2002, 62:2637-2651.
10. Roland M., Fairbank J. The Roland-Morris disability questionnaire and the Oswestry disability questionnaire. Spine 2000, 25:3115-3124.
11. Ostelo R.W., Deyo R.A., Stratford D., et al. Interpreting change scores for pain and functional status in low back pain: toward international consensus regarding minimal important change. Spine 2008, 33:90-94.
12. Deshpande A., Furlan A., Mailis-Gagnon A., et al. Opioids for chronic low back pain. Cochrane Database Syst Rev 2007, CD004959.
13. Martell B.A., O'Connor P.G., Kerns R.D., et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 2007, 146:116-127.
14. Schnitzer T.J., Gray W.L., Paster Z., et al. Efficacy of tramadol in treatment of chronic low back pain. J Rheumatol 2000, 27:772-778.
15. Jamison R.N., Raymond S., Slawsby E.A., et al. Opioid therapy for chronic noncancer back pain: a randomized prospective study. Spine 1998, 23:2591-2600.
16. Anonymous Opioids are a poor choice in chronic back pain. BMJ 2007, 334:179.
17. Chou R., Hoyt Huffman L. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians Clinical Practice Guideline. Ann Intern Med 2007, 147:504-514.
18. Giesecke T., Gracely R.H., Grant M.A., et al. Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum 2004, 50:613-623.
19. McWilliams L.A., Goodwin R.D., Cox B. Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain 2004, 111:77-83.
20. Hagen E.M., Svensen E., Eriksen H.R., et al. Comorbid subjective health complaints in low back pain. Spine 2006, 31:1491-1495.
21. Salerno S.M., Browning R., Jackson J.L. The effect of antidepressant treatment on chronic back pain. Arch Intern Med 2002, 162:19-24.
22. Staiger T.O., Gaster B., Sullivan M.D., et al. Systematic review of antidepressants in the treatment of chronic low back pain. Spine 2003, 28:2540-2545.
23. Skljarevski V., Zhang S., Desaiah D., et al. Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed dose, randomized, double-blind trial. J Pain 2010, 11:1282-1290.
24. McCleane G.J. Does gabapentin have an analgesic effect on background, movement and referred pain? A randomised, double-blind, placebo controlled study. Pain Clinic 2001, 13:103-107.
25. Staal J.B., de Bie R., de Vet H.C., et al. Injection therapy for subacute and chronic low back pain. Cochrane Database Syst Rev 2008, CD001824.
26. Bannwarth B. Irrelevance of the WHO analgesic ladder for managing rheumatic pain. Joint Bone Spine 2010, 77:1-3.
27. Artus M., van der Windt D.A., Jordan K., et al. Low back pain symptoms show a similar pattern of improvement following a wide range of primary care treatments: a systematic review of randomized clinical trials. Rheumatology 2010, 49:2346-2356.
28. Artus M., van der Windt D. Small effects of treatments for non-specific low back pain: how can we improve patients' outcomes?. Rheumatology 2009, 48:464-465.